Fecal Calprotectin Test Market
According to Intent Market Research, the Fecal Calprotectin Test Market is expected to grow from USD 1.4 Billion in 2023 at a CAGR of 10.2% to touch USD 2.7 Billion by 2030. The Fecal Calprotectin Test Market is dominated by key players such as Abbott Laboratories, Becton, Dickinson and Company (BD), bioMérieux S.A., Cepheid (Danaher Corporation), Danaher Corporation, F. Hoffmann-La Roche Ltd., Labor Diagnostika Nord GmbH, Medtronic PLC, Omega Diagnostics Group PLC, Orion Diagnostica Oy, Quidel Corporation, Roche Diagnostics and Thermo Fisher Scientific Inc.